Commentary

PSA screening: Back to the future

Eric Klein, MD
Cleveland Clinic Journal of Medicine November 2018, 85 (11) 881-883; DOI: https://doi.org/10.3949/ccjm.85a.18102

Article Information

vol. 85 no. 11 881-883
DOI 
https://doi.org/10.3949/ccjm.85a.18102
PubMed 
30395520
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online November 1, 2018.
Copyright & Usage 
Copyright © 2018 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Eric Klein, MD⇑
  1. Andrew C. Novick Distinguished Chair, Glickman Urological and Kidney Institute, and Staff, Department of Urology and Department of Cancer Biology, Cleveland Clinic; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Principal Investigator, IsoPSA study
  1. ADDRESS:
    Eric Klein, MD, Department of Urology, Q10-1, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kleine{at}ccf.org
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects